Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study

From March 1993 to February 1997, 43 eligible patients with inoperable stage IIIA (ten patients) and stage IIIB (33 patients), histologically confirmed NSCLC received 3 courses of the ICE combination (ifosfamide 1.5 g m(−2) and mesna 750 mg m(−2) two times a day, cisplatin 25 mg m(−2) and etoposide...

Descripción completa

Detalles Bibliográficos
Autores principales: Scinto, A F, Ferraresi, V, Milella, M, Tucci, E, Santomaggio, C, Pasquali-Lasagni, R, Vecchio, M R Del, Campioni, N, Nardi, M, Cognetti, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362939/
https://www.ncbi.nlm.nih.gov/pubmed/10576661
http://dx.doi.org/10.1038/sj.bjc.6690803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362939/
https://www.ncbi.nlm.nih.gov/pubmed/10576661
http://dx.doi.org/10.1038/sj.bjc.6690803

Ejemplares similares